Insider trade

Edwards Lifesciences (EW): Officer had shares withheld for tax 101 shares

Andrew M. Dahl, Officer at Edwards Lifesciences, reported a tax withholding of 101 shares.

101
Shares · @ $105.80
Traded
Nov 13, 2026
Filed
Nov 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 1, 2026FDAFDA device approval: Autus Size-Adjustable Valve
  2. Oct 5, 2026FDARecall: Generic Name: Edwards Commander M Delivery System Generic Name: Edwards Commander M Delivery System Model/Catalog Number: 9880CM29A Software Version: Not appli…
  3. Oct 8, 2026InsiderOfficer sold ~$53K of EW shares in the open market
  4. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
  5. Nov 9, 2026Insider · 2 peopleInsiders: 3 sales (~$7.4M)
  6. Nov 10, 2026InsiderOfficer sold ~$65K of EW shares in the open market

What came next

  1. Nov 19, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Edwards Lifesciences

For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.

Other recent filings by Andrew M. Dahl, SVP, Corporate Controller

The full history of Andrew M. Dahl, SVP, Corporate Controller is on the profile page.

How this filing works

Explore the data

Common questions

Which Edwards Lifesciences (EW) insider traded, and how much?

Andrew M. Dahl, Officer at Edwards Lifesciences, reported a tax withholding of 101 shares. At $105.80.

When did it happen, and when was it made public?

Traded: Nov 13, 2026. Filed: Nov 14, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Edwards Lifesciences recently?

For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the EW page.

Does this mean EW stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Edwards Lifesciences

Everything OQRO holds on this company is on its EW page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data